Vascular Biogenics Ltd (VBLT)

[staccani]

I m trying to understand the data and I wrote to IR but no replies. Can anybody help? Thanks

http://ir.vblrx.com/static-files/8e6ca5af-3400-4be6-b333-3856915a8454
Dear Sir/Madam,

in your corporate presentation (linked above) dated June 2017 you report median Overall Survival for the rGBM ph2 trial of 15 months (slides page 10) and then 59.1 weeks in slide 21 (ca 13.6m). Can you please explain the difference?

Moreover , and more importantly, you report a median OS of 810 days for the therapeutic dose platinum resistant ovarian cancer ph2 trial, whereas on slide 14, where you report number of patients living longer than 15 months, it appears that the median patient has lived 15.7 months. Where do you get this 810 days Median OS from?

Since this is very material information for investors, I would be most grateful if you could clarify the above.

Thanks and regards.